EP3303348
Naftýridín-efnasambönd sem JAK kínasa-hindrar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
26.5.2016EP published:
7.8.2019EP application number:
16728495.9
EP translation filed:
16.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
25.5.2036Expiry date:
25.5.2023
Title:
NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
Timeline
Today
26.5.2016EP application
7.8.2019EP Publication
16.10.2019Translation submitted
15.11.2019Registration published
25.5.2023Expires
Owner
Name:
Theravance Biopharma R&D IP, LLCAddress:
901 Gateway Boulevard, 94080, South San Francisco, CA, US
Inventor
Name:
HUDSON, RyanAddress:
San Jose, California, US
Name:
KOZAK, JenniferAddress:
Pacifica, California, US
Name:
FATHEREE, Paul R.Address:
San Francisco, California, US
Name:
PODESTO, Dante D.Address:
Modesto, California, US
Name:
BRANDT, Gary E.L.Address:
Alameda, California, US
Name:
FLEURY, MelissaAddress:
Brisbane, California, US
Name:
BEAUSOLEIL, Anne-MarieAddress:
Redwood City, California, US
Name:
HUANG, XiaojunAddress:
San Jose, CA, US
Name:
THALLADI, Venkat R.Address:
Foster City, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562167694 PDate:
28.5.2015Country:
US
Number:
201662312273 PDate:
23.3.2016Country:
US
Classification
Categories:
C07D 519/00, A61K 31/439, A61P 1/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.4.2020
Expires: 25.5.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 3.5.2021
Expires: 25.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 3.5.2022
Expires: 25.5.2023
Payer: Patice ehf.